SAC failure is significant in cancer because it can drive both the initiation and progression of the disease. Aneuploidy resulting from SAC failure can provide a selective advantage to cancer cells by promoting genetic diversity within a tumor. This genetic variation can facilitate the evolution of drug resistance and enable cancer cells to adapt to hostile environments, making treatment more challenging.
